Literature DB >> 6368090

Pubertal changes in net renal tubular secretion of digoxin.

L A Linday, D E Drayer, M A Khan, C Cicalese, M M Reidenberg.   

Abstract

To evaluate the effect of puberty on the net renal tubular secretion of digoxin, we measured the ratio of digoxin clearance to creatinine clearance in 23 patients aged 4 to 21 yr and correlated this ratio with both sexual maturity (Tanner stage) and chronologic age. All subjects were at steady-state levels for digoxin treatment; all had normal serum creatinine values for age as well as normal serum potassium levels. Mean ratio for immature children (n = 14, Tanner 1 through 3.5) was 1.45 +/- 0.66. Mean ratio for mature adolescents (n = 9, Tanner 4 through 5) was 0.95 +/- 0.28. The difference between the two groups was significant (P less than 0.05). When patients were regrouped by age using either 13 or 15 yr as a cutoff, the difference in ratios was no longer statistically significant. Based on 45 subjects (new and from our previous study) aged 2 mo to 80 yr, there was a significant decrease in the clearance ratio with increasing age, but when the 23 subjects aged 4 to 21 yr were analyzed separately, the correlation between ratio and age was not significant. It appears that the decrease in net renal tubular secretion of digoxin from childhood to adulthood correlates better with full sexual maturation at puberty (Tanner 4 through 5) than with chronologic age. This observation may represent a developmental change in pharmacokinetics with broader significance than for digoxin disposition alone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368090     DOI: 10.1038/clpt.1984.57

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  The relationship between clearance of theophylline and age within the adult age range.

Authors:  S H Jackson; J K Wiffen; A Johnston; C A Peverel-Cooper
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  High dose of darunavir in treatment-experienced HIV-infected adolescent results in virologic suppression and improved CD4 cell count.

Authors:  Natella Y Rakhmanina; Michael N Neely; Edmund V Capparelli
Journal:  Ther Drug Monit       Date:  2012-06       Impact factor: 3.681

Review 3.  Age-related differences in digoxin toxicity and its treatment.

Authors:  T G Wells; R A Young; G L Kearns
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

Review 4.  Personalized therapeutics: HIV treatment in adolescents.

Authors:  N Y Rakhmanina; E V Capparelli; J N van den Anker
Journal:  Clin Pharmacol Ther       Date:  2008-10-01       Impact factor: 6.875

5.  Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months.

Authors:  John T Mondick; Brendan M Johnson; Lynda J Haberer; Mark E Sale; Peter C Adamson; Charles J Coté; James M Croop; Mark W Russo; Jeffrey S Barrett; J Frank Hoke
Journal:  Eur J Clin Pharmacol       Date:  2009-10-02       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.